Insights and Innovations: A Review of the GRAPPA 2023 Trainee Symposium.

Autor: Husni ME; M.E. Husni, MD, MPH, S. Cheemalavagu, MD, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, Ohio, USA; husnie@ccf.org., Cheemalavagu S; M.E. Husni, MD, MPH, S. Cheemalavagu, MD, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, Ohio, USA., Armstrong AW; A.W. Armstrong, MD, MPH, Department of Dermatology, University of California Los Angeles, Los Angeles, California, USA., Eder L; L. Eder, MD, PhD, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
Jazyk: angličtina
Zdroj: The Journal of rheumatology [J Rheumatol] 2024 Oct 01; Vol. 51 (Suppl 2), pp. 33-38. Date of Electronic Publication: 2024 Oct 01.
DOI: 10.3899/jrheum.2024-0259
Abstrakt: The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2023 annual meeting started with the trainee symposium. This symposium showcased the exceptional research activities of dermatology and rheumatology trainees in the field of psoriatic diseases (PsDs). The following report is a summary account of the 5 oral presentations and 21 poster presentations that earned the privilege of being featured at our annual meeting. These presentations span a comprehensive spectrum, encompassing basic/translational, clinical, and outcomes research, which collectively underscore GRAPPA's profound impact on both national and international fronts in the realm of PsDs.
(Copyright © 2024 by The Journal of Rheumatology.)
Databáze: MEDLINE